Alexandria Real Estate Equities (ARE)
Owns, operates, and develops Megacampus real estate for life science and advanced-technology tenants.
Something off on this page? Send us feedback.
Owns, operates, and develops laboratory and office properties for life science and advanced-technology tenants across North American innovation clusters. Rental income centers on collaborative Megacampus ecosystems, with development, redevelopment, and a smaller venture-capital platform extending the business.
Owns, operates, and develops Class A/A+ laboratory and office properties, led by collaborative Megacampus ecosystems and supported by development and redevelopment projects. A venture-capital platform provides strategic capital to life science companies. Tenants span pharmaceutical, biotechnology, medical-device, digital-health, advanced-technology, academic, government, nonprofit, and venture organizations across Greater Boston, the San Francisco Bay Area, San Diego, Seattle, Maryland, Research Triangle, and New York City.
Clustered campuses pair specialized research space with amenities, transit access, and room for tenant expansion; longstanding relationships and build-to-suit development support leasing and redevelopment execution. The portfolio is being narrowed toward Megacampuses through non-core dispositions and lower construction commitments. Demand depends on life science funding, drug-development policy, and tenant credit, while REIT distribution rules and continued access to debt, equity, joint-venture, and asset-sale capital shape investment capacity.
Company facts
Target rangeAs of Sep 21, 2026
Latest analyst notes
| Date | Firm | Action | Prior | Current |
|---|---|---|---|---|
| Sep 21, 2026 | Evercore ISI | Reiterate | Rating: —Target: $57 | Target: $59 |
| Aug 24, 2026 | Robert W. Baird | Target | Target: $46 | Target: $52 |
| Aug 17, 2026 | Evercore ISI | Reiterate | Rating: —Target: $58 | Target: $57 |
| Aug 5, 2026 | Cantor Fitzgerald | Reiterate | Rating: —Target: $43 | Target: $52 |
| Jul 6, 2026 | Mizuho Securities | Target | Target: $172 | Target: $60 |
EPSReportedEstimate
RevenueReportedEstimate
Balance sheet, Jun 30, 2026Cash & short-term investments $470.4M · Total debt $12.81B · Total assets $34.63B · Shareholders' equity $15.55B
- Revenue
- $796.0M
- Operating income
- $25.0M
- Net income
- $12.2M
HistoryDividendAnnual yieldUpcoming
| Institutions | 99.03% | 172.56M shares | |
|---|---|---|---|
| 619 holders · as of Jun 30, 2026 | |||
| Insiders | 1.70% | 2.97M shares | |
| 31 holders · as of Sep 17, 2026 | |||
| Adds to | 100.73% | ||
174.25M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
These groups come from separate filings that can overlap, so they add to 100.73%; nothing is left for Other.
Top shareholders13F · 13D/G · Form 4
| Holder | Stake | Shares | Date |
|---|---|---|---|
BlackRock, Inc.Institution | 12.45% | 21.69M | as of Jun 30, 2026 |
Norges BankInstitution | 9.43% | 16.44M | as of Jun 30, 2026 |
Vanguard Portfolio Management LLCInstitution | 8.04% | 14.00M | as of Jun 30, 2026 |
Vanguard Capital Management LLCInstitution | 6.22% | 10.84M | as of Jun 30, 2026 |
State Street CorpInstitution | 6.08% | 10.60M | as of Jun 30, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| Sep 11, 2026 | Joel S. Marcus | director, officer: Executive Chairman | +5,000 | $49.68 |
| Sep 11, 2026 | Kristina Fukuzaki-Carlson | officer: EVP - Business Operations | −16,810 | $50.51 |
| Aug 31, 2026 | Andres Gavinet | officer: Chief Accounting Officer | −10,000 | $50.93 |
| Aug 17, 2026 | Joel S. Marcus | director, officer: Executive Chairman | +5,000 | $46.28 |
| Jun 9, 2026 | Marc E. Binda | officer: CFO & Treasurer | −2,000 | $54.00 |
- Healthpeak Properties
Lab campuses overlap in core biotech clusters
- BXP
Kendall Square and life-science pipeline overlap in core labs
- Ventas
Research and innovation campuses overlap with lab real estate
- Kilroy Realty
West Coast life-science campuses overlap in Bay Area and San Diego
Compare
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Alexandria Real Estate Equities | $54.02 | +1.27% | $9.30B | — | — | 3.1 | −12.8% |
| Healthpeak Properties | $20.72 | −0.02% | $14.28B | 59.2 | 104.7 | 4.8 | +10.5% |
| BXP | $63.72 | −0.65% | $10.23B | 34.5 | 31.1 | 2.9 | +3.1% |
| Ventas | $87.02 | −0.02% | $42.31B | 161.2 | 120.4 | 6.6 | +21.7% |
| Kilroy Realty | $34.42 | −0.51% | $4.02B | 24.2 | 81.8 | 3.7 | −6.0% |
| Median | 46.8 | 93.2 | 4.3 | +6.8% |